Brief: AFT Pharmaceuticals Logs H1 Net Income NZD 2.7 Mln
19/11/2025 19:46
Nov 20 (Reuters) - AFT Pharmaceuticals H1 EBITDA NZD 6.6 million. H1 net income NZD 2.7 million H1 net debt NZD 20.9 million H1 EBIT NZD 4.7 million H1 revenue NZD 114.9 million
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV